Skip to main content
B

Bacil Pharma Ltd. — Investor Relations & Filings

Ticker · 524516 ISIN · INE711D01018 BSE.NS Manufacturing
Filings indexed 1 across all filing types
Latest filing 2026-05-11 Regulatory Filings
Country IN India
Listing BSE.NS 524516

About Bacil Pharma Ltd.

https://bacilpharma.co.in/

Bacil Pharma Ltd. specializes in the development, production, and distribution of a broad spectrum of pharmaceutical formulations. The company’s core activities involve the manufacturing of generic medicines across multiple therapeutic categories, including anti-infectives, antibiotics, analgesics, and anti-inflammatory agents. Its product range includes solid dosage forms such as tablets and capsules, as well as liquid oral preparations. Bacil Pharma Ltd. focuses on maintaining rigorous quality assurance protocols and manufacturing standards to deliver reliable healthcare products. The organization aims to provide accessible therapeutic solutions through a structured supply chain, catering to diverse clinical requirements and patient populations.

Recent filings

Filing Released Lang Actions
Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Regulatory Filings Classification · 85% confidence The document is a formal SEBI LODR Regulation 29(1) notice to the stock exchange informing of a forthcoming Board of Directors meeting date. It does not announce any board or management changes, nor does it include financial results itself, nor is it a report publication announcement. It is a regulatory compliance disclosure, fitting the general “Regulatory Filings” category.
2026-05-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.